tiprankstipranks

Joe - New Portfolio

Shmozak

Joe
Individual Investor
Ranked #550,134 out of 858,885 TipRanks' Investors
Success Rate
44%
238 out of 544
profitable transactions
Average Return
-1.99%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 0.76%
6-Month Return▼ 21.56%
12-Month Return▼ 22.79%
YTD Return▼ 15.58%
Total Return▼ 41.11%

Best Trade

Opened at
Closed at-
Gain▲ 369.80%

Bio

My Best stock ideas. I trade often, and hold everything that I have in this portfolio.

Performance

12.88%0-12.88%
▲ 12.88%
▲ 3.56%
▲ 0.36%
Sep 2025
▲ 10.96%
▲ 2.38%
▼ 2.14%
Oct 2025
▼ 3.68%
▲ 0.19%
▼ 4.61%
Nov 2025
▼ 0.10%
▲ 0.08%
▼ 2.13%
Dec 2025
▲ 4.06%
▲ 1.47%
▼ 3.67%
Jan 2026
▼ 1.12%
▼ 0.86%
▼ 11.39%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 1.90%
Mar 2026
▲ 4.89%
▲ 4.48%
▲ 0.82%
Apr 2026
TipRanks AverageS&P 500Investor Portfolio
▲ 12.88%▲ 3.56%▲ 0.36%
▲ 10.96%▲ 2.38%▼ 2.14%
▼ 3.68%▲ 0.19%▼ 4.61%
▼ 0.10%▲ 0.08%▼ 2.13%
▲ 4.06%▲ 1.47%▼ 3.67%
▼ 1.12%▼ 0.86%▼ 11.39%
▲ 0.60%▼ 4.94%▼ 1.90%
▲ 4.89%▲ 4.48%▲ 0.82%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
ZyVersa Therapeutics
25%
▼ 40.57%
3
Open
Jan 17, 2024
FiEE
▼ 37.02%
2
Close
Jan 17, 2024
Spectaire Holdings
▼ 3.43%
2
Close
Jan 17, 2024
Nexera Technologies
▼ 10.16%
2
Close
Jan 12, 2024
Axonics Modulation Technologies
▼ 0.92%
2
Close
Jan 12, 2024
Juniper Networks
▲ 1.90%
2
Close
Jan 12, 2024
Pricesmart
▲ 0.63%
2
Close
Jan 12, 2024
Flexsteel
25%
▲ 116.62%
1
Open
Jan 12, 2024
Sentage Holdings
▼ 17.91%
4
Close
Jan 11, 2024
Harpoon Therapeutics
▲ 0.40%
2
Close
Jan 11, 2024
Ambrx Biopharma
▲ 2.26%
2
Close
Jan 11, 2024
Ainos
▼ 13.55%
4
Close
Jan 10, 2024
Aclarion, Inc.
▼ 18.92%
6
Close
Jan 10, 2024
Dyne Therapeutics
▲ 22.07%
2
Close
Jan 08, 2024
Omega Therapeutics
▼ 18.16%
2
Close
Jan 08, 2024
NexImmune
▼ 1.01%
4
Close
Jan 05, 2024
GridAI Technologies
▲ 0.42%
6
Close
Jan 05, 2024
Dermata Therapeutics
25%
▼ 59.28%
3
Open
Jan 05, 2024
Voyager Therapeutics
▼ 1.67%
2
Close
Jan 05, 2024
Cue Health
▼ 10.09%
2
Close
Jan 05, 2024